Side Chain Oxygenated Cholesterol Regulates Cellular Cholesterol Homeostasis through Direct Sterol-Membrane InteractionsS
Side chain oxysterols exert cholesterol homeostatic effects by suppression of sterol regulatory element-binding protein maturation and promoting degradation of hydroxymethylglutaryl-CoA reductase. To examine whether oxysterol-membrane interactions contribute to the regulation of cellular cholesterol...
Saved in:
Published in | The Journal of biological chemistry Vol. 284; no. 3; pp. 1755 - 1764 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Society for Biochemistry and Molecular Biology
16.01.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Side chain oxysterols exert cholesterol homeostatic effects by suppression
of sterol regulatory element-binding protein maturation and promoting
degradation of hydroxymethylglutaryl-CoA reductase. To examine whether
oxysterol-membrane interactions contribute to the regulation of cellular
cholesterol homeostasis, we synthesized the enantiomer of
25-hydroxycholesterol. Using this unique oxysterol probe, we provide evidence
that oxysterol regulation of cholesterol homeostatic responses is not mediated
by enantiospecific oxysterol-protein interactions. We show that side chain
oxysterols, but not steroid ring-modified oxysterols, exhibit membrane
expansion behavior in phospholipid monolayers and bilayers
in vitro
.
This behavior is non-enantiospecific and is abrogated by increasing the
saturation of phospholipid acyl chain constituents. Moreover, we extend these
findings into cultured cells by showing that exposure to saturated fatty acids
at concentrations that lead to endoplasmic reticulum membrane phospholipid
remodeling inhibits oxysterol activity. These studies implicate
oxysterol-membrane interactions in acute regulation of sterol homeostatic
responses and provide new insights into the mechanism through which oxysterols
regulate cellular cholesterol balance. |
---|---|
Bibliography: | Both authors contributed equally to this work. This work was supported, in whole or in part, by National Institutes of Health Grants HL67773 (to D. S. O. and D. F. C.), HL83762 (to D. S. O.), GM47969 (to D. F. C.), DK54268 (to J. E. S.), HL49180 (to H. L. B.), GM45928 (to R. E. B.), and P30 DK56341 and by Training Grant 5T32HL007275-29 (to E. J. W. and N. D.). This work was also supported by the Hormel Foundation (to H. L. B. and R. E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2. To whom correspondence should be addressed: Center for Cardiovascular Research, Washington University School of Medicine, Box 8086, 660 S. Euclid Ave., St. Louis, MO 63110. Tel.: 314-362-8737; Fax: 314-362-0186; E-mail: dory@wustl.edu. |
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M807210200 |